The Australian Medical Association (AMA) has called for an immediate suspension of category 5 medicinal cannabis and formal registration of all products within two to three years as it insisted “comprehensive reform” was needed to regulate the medicine.
In its submission to the health regulator’s consultation on medicinal cannabis, the AMA listed a catalogue of concerns, stressing the current framework is no longer “appropriate or sufficient” and was leading to adverse health outcomes.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
The AMA should probably do a little more research before making such ridiculous comments. The immediate ban of all category 5 products!? So a CBG oil should be immediately banned? A 7% THC flower should be immediately banned? It seems as though they have confused themselves with what category 5 means, CBD being <2% of the total cannabinoid profile doesn't mean it is 98% THC. You could have a very low thc % product, but if the the minor cannabinoids aren't over certain levels (quite high levels at that) then that would be deems 100% THC in relation to the categorisation. You could also have a product with 0% THC and it could be a cat 5. With that in mind, is an immediate ban on cat 5 medicines responsible, I think not. It is unsafe and inappropriate for such bodies to make these kind of remarks without understanding the outcomes of what they are recommending.